Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study
American Journal of Translational Research · 2026 · 18 (5) · 4536-4546
DOI: 10.62347/qhvy7929 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Meimei Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spleen-Stomach Diseases I, Shaanxi Provincial Hospital of Traditional Chinese Medicine Xi'an 710003, Shaanxi, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Spleen-Stomach Diseases I, Shaanxi Provincial Hospital of Traditional Chinese Medicine Xi'an 710003, Shaanxi, China.
Zitieren
APA
Zhao, M., & Yu, T. (2026). Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study. American Journal of Translational Research, 18(5), 4536-4546. https://doi.org/10.62347/qhvy7929
Vancouver
Zhao M, Yu T. Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study. American Journal of Translational Research. 2026;18(5):4536-4546. doi:10.62347/qhvy7929
BibTeX
@article{Zhao2026,
author = {Zhao, Meimei and Yu, Tao},
title = {Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {5},
pages = {4536--4546},
doi = {10.62347/qhvy7929}
}
EUVIMED